Hutchison WM, Aitken PP, Wells BWP: Chronic Toxoplasma infections and motor performance in the mouse. Ann Trop Med Parasitol. 1980, 74: 505-510.
Google Scholar
Witting PA: Learning capacity and memory of normal and Toxoplasma-infected laboratory rats and mice. Z Parasitenkd. 1979, 61: 29-51. 10.1007/BF00927085.
CAS
Article
PubMed
Google Scholar
Hutchison WM, Aitken PP, Wells BWP: Chronic Toxoplasma infection and familiarity-novelty discrimination in the mouse. Ann Trop Med Parasitol. 1980, 74: 145-150.
CAS
Article
PubMed
Google Scholar
Hay J, Hutchison WM, Aitken PP, Graham DI: The effect of congenital and adult-acquired Toxoplasma infections on activity and responsiveness to novel stimulation in mice. Ann Trop Med Parasitol. 1983, 77: 483-495.
CAS
PubMed
Google Scholar
Hay J, Aitken PP, Hair DM, Hutchison WM, Graham DI: The effect of congenital Toxoplasma infection on mouse activity and relative preference for exposed areas over a series of trials. Ann Trop Med Parasitol. 1984, 78: 611-618.
CAS
PubMed
Google Scholar
Hay J, Aitken PP, Arnott MA: The influence of Toxoplasma infection on the spontaneous running activity of mice. Z Parasitenkd. 1985, 71: 459-462. 10.1007/BF00928348.
CAS
Article
PubMed
Google Scholar
Hay J, Hutchison WM, Aitken PP: Congenital Toxoplasma infection and response to novelty in mice. Ann Trop Med Parasitol. 1983, 77: 437-439.
CAS
PubMed
Google Scholar
Hay J, Aitken PP, Graham DI: Toxoplasma infection and response to novelty in mice. Z Parasitenkd. 1984, 70: 575-588. 10.1007/BF00926588.
CAS
Article
PubMed
Google Scholar
Hrda S, Votypka J, Kodym P, Flegr J: Transient nature of Toxoplasma gondii-induced behavioral changes in mice. J Parasitol. 2000, 86: 657-663.
CAS
Article
PubMed
Google Scholar
Webster JP: The effect of Toxoplasma gondii and other parasites on activity levels in wild and hybrid Rattus norvegicus. Parasitology. 1994, 109: 583-589.
Article
PubMed
Google Scholar
Webster JP, Brunton CFA, Macdonald DW: Effect of Toxoplasma gondii upon neophobic behaviour in wild brown rats, Rattus norvegicus. Parasitology. 1994, 109: 37-43.
Article
PubMed
Google Scholar
Berdoy M, Webster JP, Macdonald DW: Fatal attraction in rats infected with Toxoplasma gondii. Proc Biol Sci. 2000, 267: 1591-1594. 10.1098/rspb.2000.1182.
CAS
Article
PubMed
PubMed Central
Google Scholar
Havlicek J, Gasova Z, Smith AP, Zvara K, Flegr J: Decrease of psychomotor performance in subjects with latent 'asymptomatic' toxoplasmosis. Parasitology. 2001, 122: 515-520. 10.1017/S0031182001007624.
CAS
Article
PubMed
Google Scholar
Flegr J, Havlicek J, Kodym P, Maly M, Smahel Z: Increased risk of traffic accidents in subjects with latent toxoplasmosis: a retrospective case-controlstudy. BMC Infect Dis. 2002, 2: art-11. 10.1186/1471-2334-2-11.
Article
Google Scholar
Flegr J, Hrdy I: Influence of chronic toxoplasmosis on some human personality factors. Folia Parasitol. 1994, 41: 122-126.
CAS
PubMed
Google Scholar
Flegr J, Zitkova S, Kodym P, Frynta D: Induction of changes in human behaviour by the parasitic protozoan Toxoplasma gondii. Parasitology. 1996, 113: 49-54.
Article
PubMed
Google Scholar
Flegr J, Kodym P, Tolarova V: Correlation of duration of latent Toxoplasma gondii infection with personality changes in women. Biol Psychol. 2000, 53: 57-68. 10.1016/S0301-0511(00)00034-X.
CAS
Article
PubMed
Google Scholar
Flegr J, Preiss M, Klose J, Havlicek J, Vitakova M, Kodym P: Decreased level of psychobiological factor novelty seeking and lower intelligence in men latently infected with the protozoan parasite Toxoplasma gondii Dopamine, a missing link between schizophrenia and toxoplasmosis?. Biol Psychol. 2003, 63: 253-268. 10.1016/S0301-0511(03)00075-9.
Article
PubMed
Google Scholar
Stibbs HH: Changes in brain concentrations of catecholamines and indoleamines in Toxoplasma gondii infected mice. Ann Trop Med Parasitol. 1985, 79: 153-157.
CAS
PubMed
Google Scholar
Minto A, Roberts FJ: The psychiatric complications of toxoplasmosis. Lancet. 1959, 1180-1182. 10.1016/S0140-6736(59)91187-0.
Google Scholar
Robertson JS: Toxoplasma skin- and dye-test surveys of severely subnormal patients in Lincolnshire. J Hyg Camb. 1965, 63: 89-98.
CAS
Article
PubMed
PubMed Central
Google Scholar
Kramer W: Frontiers of neurological diagnosis in acquired toxoplasmosis. Psych Neurol Neurochir. 1966, 69: 43-64.
CAS
Google Scholar
Ladee GA, Scholten JM, Meyes FEP: Diagnostic problems in psychiatry with regard to acquired toxoplasmosis. Psych Neurol Neurochir. 1966, 69: 65-82.
CAS
Google Scholar
Yolken RH, Bachmann S, Ruslanova I: Antibodies to Toxoplasma gondii in individuals with first- episode schizophrenia. Clin Infect Dis. 2001, 32: 1247-1247. 10.1086/319221.
CAS
Article
Google Scholar
Torrey EF, Yolken RH: Toxoplasma gondii and schizophrenia. Emerg Infect Dis. 2003, 9: 1375-1380.
Article
PubMed
PubMed Central
Google Scholar
Torrey EF, Yolken RH: Could schizophrenia be a viral zoonosis transmitted from house cats. Schizophrenia Bull. 1995, 21: 167-171. 10.1016/0920-9964(95)00042-K.
CAS
Article
Google Scholar
Torrey EF, Rawlings R, Yolken RH: The antecedents of psychoses: a case-control study of selected risk factors. Schizoph Res. 2000, 46: 17-23. 10.1016/S0920-9964(99)00237-6.
Article
Google Scholar
Torrey EF, Yolken RH: The schizophrenia-rheumatoid arthritis connection: Infectious, immune, or both?. Brain Beh Immun. 2002, 15: 401-410. 10.1006/brbi.2001.0649.
Article
Google Scholar
Cloninger CR: The genetics and psychobiology of the seven-factor model of personality. Biology of personality disorders. Edited by: Silk KR. 1998, Washington,DC, American Psychiatric Press, Inc., 63-92.
Google Scholar
Wiesbeck GA, Mauerer C, Thome J, Jakob F, Boening J: Neuroendocrine support for a relationship between "novelty seeking" and dopaminergic function in alcohol-dependent men. Psychoneuroendocrinology. 1995, 20: 755-761. 10.1016/0306-4530(95)00014-3.
CAS
Article
PubMed
Google Scholar
Ruegg RG, Gilmore J, Ekstrom RD, Corrigan M, Knight B, Tancer M, Leatherman ME, Carson SW, Golden RN: Clomipramine challenge responses covary with Tridimensional Personality Questionnaire scores in healthy subjects. Biol Psychiatry. 1997, 42: 1123-1129. 10.1016/S0006-3223(97)00009-7.
CAS
Article
PubMed
Google Scholar
Gerra G, Zaimovic A, Timpano M, Zambelli U, Begarani M, Marzocchi GF, Ferri M, Delsignore R, Brambilla F: Neuroendocrine correlates of temperament traits in abstinent opiate addicts. Journal of Substance Abuse. 2000, 11: 337-354. 10.1016/S0899-3289(00)00031-6.
CAS
Article
PubMed
Google Scholar
Hansenne M, Pinto E, Pitchot W, Reggers J, Scantamburlo G, Moor M, Ansseau M: Further evidence on the relationship between dopamine and novelty seeking: a neuroendocrine study. Person Indiv Differ. 2002, 33: 967-977. 10.1016/S0191-8869(01)00205-7.
Article
Google Scholar
Kodym P, Malý M, Svandová E, Lekatková H, Badoutová M, Vlková J, Benes C, Zástera M: Toxoplasma in the Czech Republic 1923-1999: first case to widespread outbreak. Int J Parasitol. 2000, 30: 11-18.
Google Scholar
Britt WJ: Human cytomegalovirus overview: The virus and its pathogenic mechanisms. Baillieres Clin Infect Dis. 1996, 3: 307-325.
Google Scholar
Jones J, Lopez A, Wilson M: Congenital toxoplasmosis. Am Fam Phys. 2003, 67: 2131-2138.
Google Scholar
Arribas JR, Storch GA, Clifford DB, Tselis AC: Cytomegalovirus encephalitis. Ann Intern Med. 1996, 125: 577-587.
CAS
Article
PubMed
Google Scholar
Israelski DM, Chmiel JS, Poggensee L, Phair JP, Remington JS: Prevalence of Toxoplasma infection in a cohort of homosexual men at risk of AIDS and toxoplasmic encephalitis. J Acquired Immune Defic Syndr. 1993, 6: 414-418.
CAS
Google Scholar
Da Cunha S, Ferreira E, Ramos I, Martins R, De FL, Borges JL, Corte-Real R, Mota A, Melico-Silvestre A, Furtado AL: Cerebral toxoplasmosis after renal transplantation. Case report and review. Acta Med Port. 1994, 7: S61-S66.
PubMed
Google Scholar
Cinque P, Marenzi R, Ceresa D: Cytomegalovirus infections of the nervous system. Intervirology. 1997, 40: 85-97.
CAS
Article
PubMed
Google Scholar
Arendt G, von Giesen HJ, Hefter H, Neuen-Jacob E, Roick H, Jablonowski H: Long-term course and outcome in AIDS patients with cerebral toxoplasmosis. Acta Neurol Scand. 1999, 100: 178-184.
CAS
Article
PubMed
Google Scholar
Cloninger CR, Przybeck TR, Svrakic DM, Wetzel RD: The temperament and character inventory (TCI): a guide to its development and use. 1994, Center for Psychobiology of Personality, St.Louis Missouri, Washington University Press
Google Scholar
Kožený J, Tisanská L: Formální vlastnosti dotazníku TCI testované na datech adolescentù. CS Psychol. 1998, 42: 75-83.
Google Scholar
Preiss M, Klose J: Diagnostika poruch osobnosti pomocí teorie C R Cloningera. Psychiatrie. 2003, 4: 226-231.
Google Scholar
Otis AS: Edited by: Otis Quick-Scoring Mental Ability Test, New Edition. 1954, Tarrytown-on-Hudson, NY, Word Book Co
Pokorny J, Fruhbauer Z, Polednakova S, Sykora J, Zastera M, Fialova D: Stanoveni antitoxoplasmickych protilatek IgG netodou ELISA (Assessment of antitoxoplasmatic IgG antibodies with the ELISA method). Cs Epidem. 1989, 38: 355-361.
CAS
Google Scholar
Warren J, Sabin AB: The complement fixation reaction in toxoplasmic infection. Proc Soc Exp Biol Med. 1942, 51: 11-16.
CAS
Article
Google Scholar
Rothschild DM, O'Grady M, Wecker L: Neonatal cytomegalovirus exposure decreases prepulse inhibition in adult rats: implications for schizophrenia. J Neurosci Res. 1999, 57: 429-434. 10.1002/(SICI)1097-4547(19990815)57:4<429::AID-JNR2>3.0.CO;2-D.
CAS
Article
PubMed
Google Scholar
O'Kusky JR, Boyes BE, Walker DG, McGeer EG: Cytomegalovirus infection of the developing brain alters catecholamine and indoleamine metabolism. Brain Res. 1991, 559: 322-330. 10.1016/0006-8993(91)90019-R.
Article
PubMed
Google Scholar
Dunn AJ: Systemic interleukin-1 administration stimulates hypothalamic norepinephrine metabolism parallelling the increased plasma corticosterone. Life Sci. 1988, 43: 429-435. 10.1016/0024-3205(88)90522-X.
CAS
Article
PubMed
Google Scholar
Kabiersch A, del Rey A, Honegger CG, Besedovsky HO: Interleukin-1 induces changes in norepinephrine metabolism in the rat brain. Brain Behav Immun. 1988, 2: 267-274. 10.1016/0889-1591(88)90028-1.
CAS
Article
PubMed
Google Scholar
Araujo DM, Lapchak PA, Collier B, Quirion R: Localization of interleukin-2 immunoreactivity and interleukin-2 receptors in the rat brain: interaction with the cholinergic system. Brain Res. 1989, 498: 257-266. 10.1016/0006-8993(89)91104-9.
CAS
Article
PubMed
Google Scholar
Zalcman S, Murray L, Dyck DG, Greenberg AH, Nance DM: Interleukin-2 and -6 induce behavioral-activating effects in mice. Brain Res. 1998, 811: 111-121. 10.1016/S0006-8993(98)00904-4.
CAS
Article
PubMed
Google Scholar
Alonso R, Chaudieu I, Diorio J, Krishnamurthy A, Quirion R, Boksa P: Interleukin-2 modulates evoked release of [3H]dopamine in rat cultured mesencephalic cells. J Neurochem. 1993, 61: 1284-1290.
CAS
Article
PubMed
Google Scholar
Petitto JM, McCarthy DB, Rinker CM, Huang Z, Getty T: Modulation of behavioral and neurochemical measures of forebrain dopamine function in mice by species-specific interleukin-2. J Neuroimmunol. 1997, 73: 183-190. 10.1016/S0165-5728(96)00196-8.
CAS
Article
PubMed
Google Scholar
De Sarro GB, Masuda Y, Ascioti C, Audino MG, Nistico G: Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone. Neuropharmacology. 1990, 29: 167-179. 10.1016/0028-3908(90)90057-X.
CAS
Article
PubMed
Google Scholar
Denicoff KD, Rubinow DR, Papa MZ, Simpson C, Seipp CA, Lotze MT, Chang AE, Rosenstein D, Rosenberg SA: The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann Intern Med. 1987, 107: 293-300.
CAS
Article
PubMed
Google Scholar
West WH, Tauer KW, Yannelli JR, Marshall GD, Orr DW, Thurman GB, Oldham RK: Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer. New Engl J Med. 1987, 316: 898-905.
CAS
Article
PubMed
Google Scholar
Conley FK, Jenkins KA: Immunohistological study of the anatomic relationship of Toxoplasma antigens to the inflammatory response in the brains of mice chronically infected with Toxoplasma gondii. Infect Immun. 1981, 31: 1184-1192.
CAS
PubMed
PubMed Central
Google Scholar
Arsenijevic D, Girardier L, Seydoux J, Chang HR, Dulloo AG: Altered energy balance and cytokine gene expression in a murine model of chronic infection with Toxoplasma gondii. Am J Physiol. 1997, 272: 908-917.
Google Scholar
Schluter D, Kaefer N, Hof H, Wiestler OD, Deckertschluter M: Expression pattern and cellular origin of cytokines in the normal and Toxoplasma gondii-infected murine brain. Am J Pathol. 1997, 150: 1021-1035.
CAS
PubMed
PubMed Central
Google Scholar
Denkers EY, Gazzinelli RT: Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev. 1998, 11: 569-588.
CAS
PubMed
PubMed Central
Google Scholar
Cai GF, Radzanowski T, Villegas EN, Kastelein R, Hunter CA: Identification of STAT4-dependent and independent mechanisms of resistance to Toxoplasma gondii. J Immunol. 2000, 165: 2619-2627.
CAS
Article
PubMed
Google Scholar
Fischer HG, Reichmann G: Brain dendritic cells and macrophages/microglia in central nervous system inflammation. J Immunol. 2001, 166: 2717-2726.
CAS
Article
PubMed
Google Scholar
Albrecht P, Torrey EF, Boone E, Hicks JT, Daniel N: Raised cytomegalovirus-antibody level in cerebrospinal fluid of schizophrenic patients. Lancet. 1980, 2: 769-772. 10.1016/S0140-6736(80)90386-4.
CAS
Article
PubMed
Google Scholar
Yolken RH, Torrey EF: Hypothesis of a viral etiology in bipolar disorder. Bipolar disorders. Basic mechanisms and therapeutic implications. Edited by: Soares JC and Gershon S. 2002, New York, Marcel Dekker, Inc, 305-315.
Google Scholar
Carlsson A: The current status of the dopamine hypothesis of schizophrenia. Neuropsychopharmacology. 1988, 1: 179-186. 10.1016/0893-133X(88)90012-7.
CAS
Article
PubMed
Google Scholar
Sawa A, Snyder SH: Schizophrenia: diverse approaches to a complex disease. Science. 2002, 296: 692-695. 10.1126/science.1070532.
CAS
Article
PubMed
Google Scholar
Abramsky O, Litvin Y: Automimmune response to dopamine-receptor as a possible mechanism in the pathogenesis of Parkinson's disease and schizophrenia. Perspect Biol Med. 1978, 22: 104-114.
CAS
PubMed
Google Scholar
Licinio J, Seibyl JP, Altemus M, Charney DS, Krystal JH: Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry. 1993, 150: 1408-1410.
CAS
Article
PubMed
Google Scholar
McAllister CG, van Kammen DP, Rehn TJ, Miller AL, Gurklis J, Kelley ME, Yao J, Peters JL: Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status. Am J Psychiatry. 1995, 152: 1291-1297.
CAS
Article
PubMed
Google Scholar